Astera Labs (NASDAQ:ALAB) Issues Earnings Results, Beats Expectations By $0.10 EPS

Astera Labs (NASDAQ:ALAB) posted its quarterly earnings data on Tuesday. The company reported $0.49 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.39 by $0.10, Briefing.com reports. The business had revenue of $230.58 million during the quarter, compared to the consensus estimate of $206.42 million. Astera Labs had a net margin of 16.54% and a return on equity of 9.53%. The firm’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same quarter last year, the company posted $0.23 earnings per share. Astera Labs updated its Q4 2025 guidance to 0.50-0.510 EPS.

Astera Labs Trading Down 6.4%

NASDAQ ALAB opened at $179.31 on Wednesday. Astera Labs has a 12 month low of $47.13 and a 12 month high of $262.90. The stock has a market cap of $29.80 billion, a price-to-earnings ratio of 320.20, a PEG ratio of 4.70 and a beta of 1.37. The company’s 50 day moving average is $196.79 and its two-hundred day moving average is $138.70.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. Wall Street Zen upgraded shares of Astera Labs from a “hold” rating to a “buy” rating in a research note on Monday. Susquehanna boosted their price objective on shares of Astera Labs from $80.00 to $125.00 and gave the company a “neutral” rating in a research note on Thursday, August 7th. CICC Research started coverage on shares of Astera Labs in a research report on Friday, August 29th. They set an “outperform” rating and a $190.00 target price for the company. Bank of America assumed coverage on shares of Astera Labs in a research report on Friday, October 3rd. They set a “neutral” rating and a $230.00 target price for the company. Finally, Northland Securities lowered shares of Astera Labs from an “outperform” rating to a “market perform” rating and set a $120.00 price objective for the company. in a report on Tuesday, July 22nd. Twelve analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $168.88.

Insider Buying and Selling at Astera Labs

In related news, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction on Tuesday, September 2nd. The shares were sold at an average price of $173.27, for a total value of $31,708,410.00. Following the completion of the transaction, the director directly owned 385,863 shares of the company’s stock, valued at approximately $66,858,482.01. This trade represents a 32.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction on Wednesday, October 1st. The stock was sold at an average price of $192.16, for a total value of $1,921,600.00. Following the completion of the sale, the general counsel owned 151,573 shares of the company’s stock, valued at approximately $29,126,267.68. This represents a 6.19% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last 90 days, insiders sold 1,092,997 shares of company stock worth $192,231,120. Insiders own 12.50% of the company’s stock.

Institutional Trading of Astera Labs

A number of institutional investors have recently bought and sold shares of ALAB. Diversify Wealth Management LLC bought a new stake in shares of Astera Labs during the second quarter worth $106,000. Visionary Wealth Advisors bought a new stake in shares of Astera Labs during the second quarter worth $205,000. Tower Research Capital LLC TRC lifted its position in shares of Astera Labs by 506.3% during the second quarter. Tower Research Capital LLC TRC now owns 2,486 shares of the company’s stock worth $225,000 after purchasing an additional 2,076 shares during the last quarter. Ausdal Financial Partners Inc. bought a new stake in shares of Astera Labs during the second quarter worth $257,000. Finally, Empowered Funds LLC lifted its position in shares of Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.